Astellas Pharma Inc.
ALPMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $188 | $336 | $377 | $316 |
| Short-Term Investments | $30 | $29 | $20 | $21 |
| Receivables | $633 | $535 | $428 | $382 |
| Inventory | $297 | $249 | $174 | $153 |
| Other Curr. Assets | $53 | $47 | $51 | $51 |
| Total Curr. Assets | $1,201 | $1,195 | $1,050 | $923 |
| Property Plant & Equip (Net) | $329 | $294 | $286 | $269 |
| Goodwill | $415 | $419 | $328 | $303 |
| Intangibles | $1,124 | $1,454 | $562 | $623 |
| Long-Term Investments | $172 | $144 | $91 | $141 |
| Tax Assets | $98 | $0 | $84 | $72 |
| Other NC Assets | $0 | $64 | $54 | -$0 |
| Total NC Assets | $2,138 | $2,375 | $1,407 | $1,409 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,340 | $3,570 | $2,457 | $2,332 |
| Liabilities | – | – | – | – |
| Payables | $188 | $185 | $140 | $131 |
| Short-Term Debt | $267 | $487 | $89 | $158 |
| Tax Payable | $35 | $39 | $5 | $32 |
| Deferred Revenue | $0 | $0 | -$89 | -$158 |
| Other Curr. Liab. | $573 | $575 | $581 | $524 |
| Total Curr. Liab. | $1,062 | $1,286 | $726 | $687 |
| LT Debt | $565 | $518 | $111 | $56 |
| Deferred Rev, NC | $0 | $71 | $121 | $0 |
| Deferred Tax Liab, NC | $5 | $51 | $6 | $0 |
| Other NC Liab. | $194 | $96 | $51 | $129 |
| Total NC Liab. | $765 | $688 | $223 | $185 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $86 | $75 | $73 |
| Total Liabilities | $1,826 | $1,974 | $949 | $872 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $103 | $103 | $103 | $103 |
| Retained Earnings | $741 | $809 | $908 | $944 |
| AOCI | $522 | $533 | $341 | $248 |
| Other Equity | $148 | $150 | $156 | $166 |
| Total Equity | $1,513 | $1,596 | $1,508 | $1,460 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,340 | $3,570 | $2,457 | $2,332 |
| Net Debt | $643 | $670 | -$177 | -$103 |